These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17573817)

  • 21. Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologists.
    Vroom F; van de Laar MA; van Roon EN; Brouwers JR; de Jong-van den Berg LT
    J Clin Pharm Ther; 2008 Feb; 33(1):39-44. PubMed ID: 18211615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the organization of an early arthritis clinic.
    Klareskog L; Nordmark B; Lindblad S
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):1-15. PubMed ID: 11358411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis patients' education - contents and methods.
    Mäkeläinen P; Vehviläinen-Julkunen K; Pietilä AM
    J Clin Nurs; 2007 Nov; 16(11C):258-67. PubMed ID: 17931319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
    Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New drugs against rheumatoid arthritis. Improved treatment options place new demands on health care organization].
    Klareskog L; Hafström I; Saxne T; Hedin PJ
    Lakartidningen; 2000 Nov; 97(48):5628-32. PubMed ID: 11187380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.
    Black RJ; Lester S; Buchbinder R; Barrett C; Lassere M; March L; Whittle S; Hill CL
    Arthritis Res Ther; 2017 Nov; 19(1):253. PubMed ID: 29141677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatology. Part 2: The role of medication.
    Byrne J
    Prof Nurse; 1999 Feb; 14(5):353-8. PubMed ID: 10205553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis. OMERACT Drug Safety Working Party.
    Lipani JA; Strand V; Johnson K; Woodworth T; Furst D; Singh G; Day R; Brooks P;
    J Rheumatol; 2001 May; 28(5):1170-3. PubMed ID: 11361208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 33. Rheumatoid arthritis registries in Sweden.
    van Vollenhoven RF; Askling J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
    Levälampi T; Korpela M; Vuolteenaho K; Moilanen E
    Scand J Rheumatol; 2008; 37(1):6-12. PubMed ID: 18189188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on biologics in juvenile idiopathic arthritis.
    Ilowite NT
    Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.
    Sokka T; Pincus T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S178-81. PubMed ID: 16273804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease.
    Richards JS; Dowell SM; Quinones ME; Kerr GS
    BMJ; 2015 Aug; 351():h3658. PubMed ID: 26282936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.